Mode
Text Size
Log in / Sign up
Phase 4 Completed N=71 Randomized Quadruple-blind Treatment

Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?

Sickle Cell Anemia Crisis
Source: ClinicalTrials.gov NCT03541980 ↗
Enrolled (actual)
71
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcomePrimary: Cumulative Opioid Dosing — .2; .2 mg/kg
◆ Published Evidence
Emerging
16citations · ~3 / year
Does Intravenous Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises?
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2021 · Open access · Likely link

Summary

The purpose of this study is to determine whether IV acetaminophen can decrease the need for subsequent opioid administration in the acute management of sickle cell crisis pain in the pediatric emergency room.

Linked Publications

  • Does Intravenous Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises?
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2021 · 16 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Cumulative Opioid Dosing
.2; .2
SECONDARY
Pain Scores
5.5; 5.2
SECONDARY
Inpatient Admission
25; 21
SECONDARY
Adverse Effects
0; 0
SECONDARY
Percentage of the Patients Reporting Satisfaction
84; 85

Eligibility Criteria

Inclusion Criteria

  • Any patient age 4-16 years with sickle cell disease who presents the Pediatric ER with acute sickle cell pain crisis with a pain of 6/10 or higher

Exclusion Criteria

  • Patient with fever (38C or 100.4F)
  • Patient less than age 4 years
  • Patient greater than age 16 years
  • Patient with hypersensitivity/allergy to either morphine, NSAIDs, or acetaminophen
  • Patient received acetaminophen within the past 4 hours
  • Patient with known liver disease or renal disease
  • Patient not requiring IV morphine (pain score 5/10 or less)
  • Patient enrolled in the study within the past 72 hours
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03541980) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search